These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 15333648)

  • 21. Marker genes for circulating tumour cells predict survival in metastasized breast cancer patients.
    Weigelt B; Bosma AJ; Hart AA; Rodenhuis S; van 't Veer LJ
    Br J Cancer; 2003 Apr; 88(7):1091-4. PubMed ID: 12671691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The melanoma antigen gene as a surveillance marker for the detection of circulating tumor cells in patients with breast carcinoma.
    Kwon S; Kang SH; Ro J; Jeon CH; Park JW; Lee ES
    Cancer; 2005 Jul; 104(2):251-6. PubMed ID: 15937912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A seminested RT-PCR assay for HER2/neu: initial validation of a new method for the detection of disseminated breast cancer cells.
    Wasserman L; Dreilinger A; Easter D; Wallace A
    Mol Diagn; 1999 Mar; 4(1):21-8. PubMed ID: 10229771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Detection of disseminated carcinoma cells in bone marrow and peripheral blood in primary breast cancer with RT/PCR of parathyroid hormone-related protein (PTHrP)].
    Liersch T; Gatzemeier W; Scharnberg P; Jürgens B; Wörmann B; Becker H; Rauschecker HF; Hiddemann W; Wulf GG
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):277-80. PubMed ID: 14518259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of immunocytochemistry, reverse transcriptase polymerase chain reaction, and nucleic acid sequence-based amplification for the detection of circulating breast cancer cells.
    Lambrechts AC; Bosma AJ; Klaver SG; Top B; Perebolte L; van' t Veer LJ; Rodenhuis S
    Breast Cancer Res Treat; 1999 Aug; 56(3):219-31. PubMed ID: 10573113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The detection of circulating breast cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction.
    Bae JW; Choi KH; Kim HG; Park SH
    J Korean Med Sci; 2000 Apr; 15(2):194-8. PubMed ID: 10803697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monitoring of tumor cell purging after highly efficient immunomagnetic selection of CD34 cells from leukapheresis products in breast cancer patients: comparison of immunocytochemical tumor cell staining and reverse transcriptase-polymerase chain reaction.
    Mapara MY; Körner IJ; Hildebrandt M; Bargou R; Krahl D; Reichardt P; Dörken B
    Blood; 1997 Jan; 89(1):337-44. PubMed ID: 8978310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Markers of circulating breast cancer cells.
    López-Muñoz E; Méndez-Montes M
    Adv Clin Chem; 2013; 61():175-224. PubMed ID: 24015603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction.
    Burchill SA; Bradbury MF; Pittman K; Southgate J; Smith B; Selby P
    Br J Cancer; 1995 Feb; 71(2):278-81. PubMed ID: 7530983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The molecular detection of micrometastatic breast cancer.
    Baker M; Gillanders WE; Mikhitarian K; Mitas M; Cole DJ
    Am J Surg; 2003 Oct; 186(4):351-8. PubMed ID: 14553849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of tumor cell-specific mRNA in the peripheral blood of patients with breast cancer—evaluation of several markers with real-time reverse transcription-PCR.
    Andergassen U; Hofmann S; Kölbl AC; Schindlbeck C; Neugebauer J; Hutter S; Engelstädter V; Ilmer M; Friese K; Jeschke U
    Int J Mol Sci; 2013 Jan; 14(1):1093-104. PubMed ID: 23299436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epithelial‑mesenchymal transition was identified as a potential marker for breast cancer aggressiveness using reverse transcription‑quantitative polymerase chain reaction.
    Andergassen U; Schlenk K; Jeschke U; Sommer H; Kölbl A
    Mol Med Rep; 2018 Aug; 18(2):1733-1739. PubMed ID: 29845200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Missed micrometastatic disease in breast cancer.
    Quan ML; Cody HS
    Semin Oncol; 2004 Jun; 31(3):311-7. PubMed ID: 15190487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human mammaglobin RT-PCR assay for detection of occult breast cancer cells in hematopoietic products.
    Silva AL; Tomé MJ; Correia AE; Passos-Coelho JL
    Ann Oncol; 2002 Mar; 13(3):422-9. PubMed ID: 11996474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular strategy for detecting metastatic cancers with use of multiple tumor-specific MAGE-A genes.
    Miyashiro I; Kuo C; Huynh K; Iida A; Morton D; Bilchik A; Giuliano A; Hoon DS
    Clin Chem; 2001 Mar; 47(3):505-12. PubMed ID: 11238304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of cytokeratin 19, human mammaglobin, and carcinoembryonic antigen-positive circulating tumor cells by three-marker reverse transcription-PCR assay and its relation to clinical outcome in early breast cancer.
    Chen Y; Zou TN; Wu ZP; Zhou YC; Gu YL; Liu X; Jin CG; Wang XC
    Int J Biol Markers; 2010; 25(2):59-68. PubMed ID: 20586026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of three molecular assays for the detection and molecular characterization of circulating tumor cells in breast cancer.
    Strati A; Kasimir-Bauer S; Markou A; Parisi C; Lianidou ES
    Breast Cancer Res; 2013 Mar; 15(2):R20. PubMed ID: 23497487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of cancer cells in peripheral blood of breast cancer patients using reverse transcription-polymerase chain reaction for epidermal growth factor receptor.
    Leitzel K; Lieu B; Curley E; Smith J; Chinchilli V; Rychlik W; Lipton A
    Clin Cancer Res; 1998 Dec; 4(12):3037-43. PubMed ID: 9865918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combining mammaglobin and carcinoembryonic mRNA markers for early detection of micrometastases from breast cancers--a molecular study of 59 patients.
    Ghaffari SR; Sabokbar T; Tahmasebi S; Dastan J; Shorakae S; Moradi A; Tirgari F; Mohagheghi MA; Mosavi-Jarrahi A
    Asian Pac J Cancer Prev; 2006; 7(3):396-8. PubMed ID: 17059329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease.
    Taback B; Chan AD; Kuo CT; Bostick PJ; Wang HJ; Giuliano AE; Hoon DS
    Cancer Res; 2001 Dec; 61(24):8845-50. PubMed ID: 11751407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.